Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (79)
  • 2024 (109)
  • 2023 (101)
  • 2022 (60)
  • 2021 (32)
  • 2020 (8)
  • 2019 (2)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (230)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (242)
  • Fentanyl Awareness (152)

Drug Name

  • Fentanyl (106)
  • Opioids (47)
  • Oxycodone (37)
  • Methamphetamine (18)
  • Synthetic Opioids (15)
  • Hydromorphone (13)
  • Cocaine (8)
  • Benzodiazepines (7)
  • Heroin (7)
  • Morphine (6)
  • Marijuana (Cannabis) (4)
  • Amphetamines (3)
  • Methadone (3)
  • Steroids (3)
  • Ketamine (1)
  • Marijuana Concentrates (1)
  • Xylazine (1)

Field Division

  • Washington, DC (41)
  • Houston (40)
  • New England (35)
  • New York (29)
  • Seattle (28)
  • Omaha (23)
  • Atlanta (19)
  • Chicago (19)
  • New Jersey (17)
  • Rocky Mountain (17)
  • Headquarters (16)
  • Miami (15)
  • Louisville (14)
  • New Orleans (14)
  • St. Louis (14)
  • Los Angeles (13)
  • El Paso (10)
  • Phoenix (8)
  • San Francisco (8)
  • Dallas (5)
  • San Diego (4)
  • Detroit (1)
Clear All Results
PRESS RELEASE

DEA Chicago Suspends Registration of Suburban Chicago Pharmacy

April 28, 2022
CHICAGO – Robert Bell, Special Agent in Charge of the U.S. Drug Enforcement Administration - Chicago Division, announced that on April 27, 2022, DEA Chicago Diversion Investigators delivered an Immediate Suspension Order to Evergreen Park Pharmacy, located at 2850 W. 95th Street, Suite 100, Evergreen Park, Illinois, suspending its DEA...
April 28, 2022
PRESS RELEASE

Richland Physician Sentenced for Conspiring to Distribute Medically Unnecessary Fentanyl Patches, Opioid Pills and Other Controlled Substances

April 28, 2022
SPOKANE, Wash. – Senior U.S. District Judge Edward F. Shea has sentenced Dr. Janet Sue Arnold, age 63, of Benton City, Washington, to 48 months in federal prison for conspiring to distribute and possess with intent to distribute opioid pain medications and other controlled substances without a legitimate medical purpose...
April 28, 2022
PRESS RELEASE

Two Naturopaths Agree to Pay $32,000 in Civil Penalties For Improper Prescription of Opioids and Controlled Substances

April 25, 2022
SPOKANE, Wash.– Dr. Jacqueline Thomas, N.D., an East Wenatchee-based naturopathic doctor, and Dr. Rebecka Hoppins, an Edmonds-based naturopathic doctor, have each agreed to pay $16,500 to resolve allegations under the Controlled Substances Act that they improperly prescribed controlled substances. The Controlled Substances Act regulates certain drugs deemed to pose a...
April 25, 2022
PRESS RELEASE

Former El Paso Physician Agrees to Pay $350,000 to Resolve Allegations

April 25, 2022
EL PASO, Texas – Dr. Herbert Nassour, a former physician in El Paso, has agreed to pay $350,000 under a civil settlement to resolve allegations he violated certain provisions of the Controlled Substances Act (CSA). Dr. Nassour was a physician registered with the Drug Enforcement Administration (DEA) to prescribe and...
April 25, 2022
PRESS RELEASE

DEA Holds 22nd National Prescription Drug Take Back Day to prevent addiction and reduce overdose deaths

April 15, 2022
EL PASO – The Drug Enforcement Administration will host its 22nd National Prescription Drug Take Back Day on Saturday, April 30 from 10 a.m. to 2 p.m. This bi-annual event offers free, anonymous disposal of unneeded medications at more than 4,000 local drop-off locations nationwide. “Disposing of unneeded medications can...
April 15, 2022
PRESS RELEASE

Prisma Health Midlands to Pay $1 Million to Resolve Alleged Controlled Substance Act Violations

April 05, 2022
COLUMBIA, SOUTH CAROLINA — Prisma Health Midlands (“Prisma”) has agreed to pay a record $1 million to resolve allegations that it committed recordkeeping and dispensing violations of the Controlled Substances Act (CSA). These requirements are designed to prevent the diversion of controlled substances. This civil settlement includes a memorandum of...
April 05, 2022
PRESS RELEASE

DEA Chicago Suspends Registration Number of Suburban Chicago Physician

March 04, 2022
CHICAGO – Robert Bell, Special Agent in Charge of the U.S. Drug Enforcement Administration - Chicago Division, announced that on March 3, 2022, DEA Chicago Diversion Investigators served an Immediate Suspension Order on Faris Abusharif, M.D., for allegedly committing acts that render the continued use of his DEA Registration inconsistent...
March 04, 2022
PRESS RELEASE

Former Nurse at Danville Hospital Sentenced for Tampering with Prescription Opioid Drugs, Making False Statements

March 04, 2022
DANVILLE, Va. – A former registered nurse working at Sovah Health-Danville was sentenced today to 36 months in federal prison for tampering with consumer products (fentanyl and hydromorphone) and making false statements. Emilee Kathryn Poteat, 31, pleaded guilty in May 2021 to one count of tampering with consumer products (fentanyl...
March 04, 2022
PRESS RELEASE

Richland Naturopath Agrees to Pay $70,096 for Improper Prescription of Controlled Substances

February 16, 2022
Richland, Wash. – Judith K. Caporiccio, N.D., a Richland-based naturopathic doctor, has agreed to pay $70,096 to resolve allegations under the Controlled Substances Act and the False Claims Act, which allege that she improperly prescribed controlled substances between July 2016 and July 2021. The Controlled Substances Act regulates certain drugs...
February 16, 2022
PRESS RELEASE

Illinois Dentist Charged with Tampering with Drugs Administered to Patients and Other Crimes

February 10, 2022
SPRINGFIELD, Ill. – Robert Bell, Special Agent in Charge of the Drug Enforcement Administration-Chicago Division, and U.S. Attorney Gregory K. Harris of the Central District of Illinois announced that a federal grand jury returned an indictment against Phillip Jensen, DMD, 61, of Rochester, Illinois, on Feb. 1, 2022, charging him...
February 10, 2022
Showing 331 - 340 of 391 results

Pagination

  • First page «
  • Previous page ‹
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • Current page 34
  • Page 35
  • Page 36
  • Page 37
  • Page 38
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster